Dunn Gordon — SEC Form 4 filings

SEC reporting owner CIK 1958139. 3 Form 4 filings on record with FilingPulse; latest filed 2024-12-27.

Transaction summary — filings shown

Covers all 3 filings on record, filed 2024-09-11 to 2024-12-27. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Quoin Pharmaceuticals, Ltd. (QNRX)Chief Financial Officer36 legs · 151,077 sh · $78,2043

Form 4 filings — Dunn Gordon

FiledFormIssuerReported transactionsSource
2024-12-274Quoin Pharmaceuticals, Ltd. (QNRX)Purchase (P): 122,221 @ $0.45 · Purchase (P): 122,221 (derivative) · Purchase (P): 122,221 (derivative)EDGAR
2024-12-104Quoin Pharmaceuticals, Ltd. (QNRX)Grant/award (A): 338,994 (derivative) @ $0EDGAR
2024-09-114Quoin Pharmaceuticals, Ltd. (QNRX)Purchase (P): 856 @ $0.80 · Purchase (P): 4,000 @ $0.78 · Purchase (P): 4,000 @ $0.80 · Purchase (P): 10,000 @ $0.91 · Purchase (P): 10,000 @ $0.71EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1958139 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →